Literature DB >> 24049166

Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Antoine Chaillon1, Gabriel A Wagner, N Lance Hepler, Susan J Little, Sergei L Kosakovsky Pond, Gemma Caballero, Mary E Pacold, Pham Phung, Terri Wrin, Douglas D Richman, Joel O Wertheim, Davey M Smith.   

Abstract

Investigating the incidence and prevalence of HIV-1 superinfection is challenging due to the complex dynamics of two infecting strains. The superinfecting strain can replace the initial strain, be transiently expressed, or persist along with the initial strain in distinct or in recombined forms. Various selective pressures influence these alternative scenarios in different HIV-1 coding regions. We hypothesized that the potency of the neutralizing antibody (NAb) response to autologous viruses would modulate viral dynamics in env following superinfection in a limited set of superinfection cases. HIV-1 env pyrosequencing data were generated from blood plasma collected from 7 individuals with evidence of superinfection. Viral variants within each patient were screened for recombination, and viral dynamics were evaluated using nucleotide diversity. NAb responses to autologous viruses were evaluated before and after superinfection. In 4 individuals, the superinfecting strain replaced the original strain. In 2 individuals, both initial and superinfecting strains continued to cocirculate. In the final individual, the surviving lineage was the product of interstrain recombination. NAb responses to autologous viruses that were detected within the first 2 years of HIV-1 infection were weak or absent for 6 of the 7 recently infected individuals at the time of and shortly following superinfection. These 6 individuals had detectable on-going viral replication of distinct superinfecting virus in the env coding region. In the remaining case, there was an early and strong autologous NAb response, which was associated with extensive recombination in env between initial and superinfecting strains. This extensive recombination made superinfection more difficult to identify and may explain why the detection of superinfection has typically been associated with low autologous NAb titers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24049166      PMCID: PMC3838120          DOI: 10.1128/JVI.02260-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology.

Authors:  Wayne Delport; Art F Y Poon; Simon D W Frost; Sergei L Kosakovsky Pond
Journal:  Bioinformatics       Date:  2010-07-29       Impact factor: 6.937

3.  GARD: a genetic algorithm for recombination detection.

Authors:  Sergei L Kosakovsky Pond; David Posada; Michael B Gravenor; Christopher H Woelk; Simon D W Frost
Journal:  Bioinformatics       Date:  2006-11-16       Impact factor: 6.937

4.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.

Authors:  Davey M Smith; Matthew C Strain; Simon D W Frost; Satish K Pillai; Joseph K Wong; Terri Wrin; Yang Liu; Christos J Petropolous; Eric S Daar; Susan J Little; Douglas D Richman
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.

Authors:  Mary E Pacold; Sergei L Kosakovsky Pond; Gabriel A Wagner; Wayne Delport; Daniel L Bourque; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

6.  Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

Authors:  R Shibata; C Siemon; M W Cho; L O Arthur; S M Nigida; T Matthews; L A Sawyer; A Schultz; K K Murthy; Z Israel; A Javadian; P Frost; R C Kennedy; H C Lane; M A Martin
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

8.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data.

Authors:  Osvaldo Zagordi; Arnab Bhattacharya; Nicholas Eriksson; Niko Beerenwinkel
Journal:  BMC Bioinformatics       Date:  2011-04-26       Impact factor: 3.307

10.  Viral population estimation using pyrosequencing.

Authors:  Nicholas Eriksson; Lior Pachter; Yumi Mitsuya; Soo-Yon Rhee; Chunlin Wang; Baback Gharizadeh; Mostafa Ronaghi; Robert W Shafer; Niko Beerenwinkel
Journal:  PLoS Comput Biol       Date:  2008-05-09       Impact factor: 4.475

View more
  11 in total

1.  Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Authors:  Gabriel A Wagner; Elise Landais; Gemma Caballero; Pham Phung; Sergei L Kosakovsky Pond; Pascal Poignard; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.

Authors:  Jouni Vesa; Antoine Chaillon; Gabriel A Wagner; Christy M Anderson; Douglas D Richman; Davey M Smith; Susan J Little
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

3.  HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.

Authors:  Christoph C Carter; Gabriel A Wagner; George K Hightower; Gemma Caballero; Pham Phung; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2014-11-11       Impact factor: 3.616

4.  Reduced frequency of HIV superinfection in a high-risk cohort in Zambia.

Authors:  Evonne Woodson; Debby Basu; Hope Olszewski; Jill Gilmour; Ilene Brill; William Kilembe; Susan Allen; Eric Hunter
Journal:  Virology       Date:  2019-06-15       Impact factor: 3.616

5.  Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.

Authors:  Debby Basu; Peng Xiao; Zachary Ende; Alfred Bere; William J Britt; Joseph Mulenga; William Kilembe; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

6.  Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine Odem-Davis; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  Dual Infection Contributes to Rapid Disease Progression in Men Who Have Sex With Men in China.

Authors:  Hong Luan; Xiaoxu Han; Xiaoou Yu; Minghui An; Hui Zhang; Bin Zhao; Junjie Xu; Zhenxing Chu; Hong Shang
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

8.  Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.

Authors:  Colleen R Courtney; Luzia Mayr; Aubin J Nanfack; Andrew N Banin; Michael Tuen; Ruimin Pan; Xunqing Jiang; Xiang-Peng Kong; Allison R Kirkpatrick; Daniel Bruno; Craig A Martens; Lydia Sykora; Stephen F Porcella; Andrew D Redd; Thomas C Quinn; Phillipe N Nyambi; Ralf Dürr
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

9.  Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population.

Authors:  Laura Hebberecht; Leen Vancoillie; Marlies Schauvliege; Delfien Staelens; Kenny Dauwe; Virginie Mortier; Chris Verhofstede
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

10.  Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.

Authors:  Yehuda Z Cohen; Julio C C Lorenzi; Lisa Krassnig; John P Barton; Leah Burke; Joy Pai; Ching-Lan Lu; Pilar Mendoza; Thiago Y Oliveira; Christopher Sleckman; Katrina Millard; Allison L Butler; Juan P Dizon; Shiraz A Belblidia; Maggi Witmer-Pack; Irina Shimeliovich; Roy M Gulick; Michael S Seaman; Mila Jankovic; Marina Caskey; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2018-08-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.